493 related articles for article (PubMed ID: 26683615)
1. HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter.
Turrini F; Marelli S; Kajaste-Rudnitski A; Lusic M; Van Lint C; Das AT; Harwig A; Berkhout B; Vicenzi E
Retrovirology; 2015 Dec; 12():104. PubMed ID: 26683615
[TBL] [Abstract][Full Text] [Related]
2. TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elements.
Kajaste-Rudnitski A; Marelli SS; Pultrone C; Pertel T; Uchil PD; Mechti N; Mothes W; Poli G; Luban J; Vicenzi E
J Virol; 2011 May; 85(10):5183-96. PubMed ID: 21345949
[TBL] [Abstract][Full Text] [Related]
3. Transcription of the human immunodeficiency virus type 1 (HIV-1) promoter in central nervous system cells: effect of YB-1 on expression of the HIV-1 long terminal repeat.
Sawaya BE; Khalili K; Amini S
J Gen Virol; 1998 Feb; 79 ( Pt 2)():239-46. PubMed ID: 9472608
[TBL] [Abstract][Full Text] [Related]
4. Semen Exosomes Promote Transcriptional Silencing of HIV-1 by Disrupting NF-κB/Sp1/Tat Circuitry.
Welch JL; Kaddour H; Schlievert PM; Stapleton JT; Okeoma CM
J Virol; 2018 Nov; 92(21):. PubMed ID: 30111566
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
[TBL] [Abstract][Full Text] [Related]
6. Induction of Sp1 phosphorylation and NF-kappa B-independent HIV promoter domain activity in T lymphocytes stimulated by okadaic acid.
Vlach J; Garcia A; Jacqué JM; Rodriguez MS; Michelson S; Virelizier JL
Virology; 1995 Apr; 208(2):753-61. PubMed ID: 7747447
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
8. Regulation of HIV-1 gene expression by NF-IL6.
Tesmer VM; Bina M
J Mol Biol; 1996 Sep; 262(3):327-35. PubMed ID: 8844998
[TBL] [Abstract][Full Text] [Related]
9. The interferon-stimulated gene TRIM22: A double-edged sword in HIV-1 infection.
Vicenzi E; Poli G
Cytokine Growth Factor Rev; 2018 Apr; 40():40-47. PubMed ID: 29650252
[TBL] [Abstract][Full Text] [Related]
10. Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants.
de Arellano ER; Alcamí J; López M; Soriano V; Holguín A
Antiviral Res; 2010 Nov; 88(2):152-9. PubMed ID: 20713090
[TBL] [Abstract][Full Text] [Related]
11. The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter.
Gómez-Gonzalo M; Carretero M; Rullas J; Lara-Pezzi E; Aramburu J; Berkhout B; Alcamí J; López-Cabrera M
J Biol Chem; 2001 Sep; 276(38):35435-43. PubMed ID: 11457829
[TBL] [Abstract][Full Text] [Related]
12. Identification of TRIM22 single nucleotide polymorphisms associated with loss of inhibition of HIV-1 transcription and advanced HIV-1 disease.
Ghezzi S; Galli L; Kajaste-Rudnitski A; Turrini F; Marelli S; Toniolo D; Casoli C; Riva A; Poli G; Castagna A; Vicenzi E
AIDS; 2013 Sep; 27(15):2335-44. PubMed ID: 23921607
[TBL] [Abstract][Full Text] [Related]
13. Interferon-inducible TRIM22 contributes to maintenance of HIV-1 proviral latency in T cell lines.
Turrini F; Saliu F; Forlani G; Das AT; Van Lint C; Accolla RS; Berkhout B; Poli G; Vicenzi E
Virus Res; 2019 Aug; 269():197631. PubMed ID: 31136823
[TBL] [Abstract][Full Text] [Related]
14. TAR and Sp1-independent transactivation of HIV long terminal repeat by the Tat protein in the presence of human cytomegalovirus IE1/IE2.
Dal Monte P; Landini MP; Sinclair J; Virelizier JL; Michelson S
AIDS; 1997 Mar; 11(3):297-303. PubMed ID: 9147420
[TBL] [Abstract][Full Text] [Related]
15. Sp1 and related factors fail to interact with the NF-kappaB-proximal G/C box in the LTR of a replication competent, brain-derived strain of HIV-1 (YU-2).
Millhouse S; Krebs FC; Yao J; McAllister JJ; Conner J; Ross H; Wigdahl B
J Neurovirol; 1998 Jun; 4(3):312-23. PubMed ID: 9639074
[TBL] [Abstract][Full Text] [Related]
16. O-linked N-acetylglucosaminylation of Sp1 inhibits the human immunodeficiency virus type 1 promoter.
Jochmann R; Thurau M; Jung S; Hofmann C; Naschberger E; Kremmer E; Harrer T; Miller M; Schaft N; Stürzl M
J Virol; 2009 Apr; 83(8):3704-18. PubMed ID: 19193796
[TBL] [Abstract][Full Text] [Related]
17. Basal and Tat-transactivated expression from the human immunodeficiency virus type 1 long terminal repeat in human placental trophoblast rules out promoter-enhancer activation as the partial block to viral replication.
Zachar V; Ebbesen P; Thomas RA; Zacharova V; Goustin AS
J Gen Virol; 1994 Jun; 75 ( Pt 6)():1461-8. PubMed ID: 8207411
[TBL] [Abstract][Full Text] [Related]
18. Activation of the human immunodeficiency virus type 1 long terminal repeat by transforming mutants of human p53.
Subler MA; Martin DW; Deb S
J Virol; 1994 Jan; 68(1):103-10. PubMed ID: 8254719
[TBL] [Abstract][Full Text] [Related]
19. The NF-kappa B and Sp1 motifs of the human immunodeficiency virus type 1 long terminal repeat function as novel thyroid hormone response elements.
Desai-Yajnik V; Samuels HH
Mol Cell Biol; 1993 Aug; 13(8):5057-69. PubMed ID: 8393143
[TBL] [Abstract][Full Text] [Related]
20. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
Chang LJ; Zhang C
Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
